Further, the combination of an oncolytic virus expressing IL-12 together with the two immune checkpoint inhibitors anti-CTLA-4 and anti-PD1 was able to significantly reduce tumour growth in GBM intracranial mouse models [58]. This evidence concerns the gene CTLA4 and glioblastoma.